ADD-Vantage Lilly
Executive Summary
Keflin, Kefzol, Mandol will be marketed in Abbott's I.V. admixture system, the firms announced Sept. 13. Release says the three drugs will be marketed in the system in "early 1985." Other Lilly drugs will be packaged in the system later. Letter of intent on the agreement was signed in June